G. Lema et al., RENAL PROTECTION IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS WITH PREOPERATIVE ABNORMAL RENAL-FUNCTION, Anesthesia and analgesia, 86(1), 1998, pp. 3-8
We prospectively studied the effects of renal protection intervention
in 17 patients with preoperative abnormal renal function (plasma creat
inine >1.5 mg/dL) scheduled for elective coronary surgery. Patients we
re randomized to either dopamine 2.0 ,mu g.kg(-1).min(-1) (Group 1, n
= 10) or perfusion pressure >70 mm Hg during cardiopulmonary bypass (C
PB) (Group 2, n = 7). Glomerular filtration rate and effective renal p
lasma flow were measured with inulin and I-125-hippuran clearances bef
ore the induction of anesthesia, after sternotomy and before CFB, duri
ng hypo-and normothermic CPB, after sternal closure, and 1 h postopera
tively. Plasma and urine electrolytes were measured, and free water, o
smolar, and creatinine clearances, as well as fractional excretion of
sodium and potassium, were calculated ed before and after surgery. Sig
nificant differences between groups were found before CPB for glomerul
ar filtration rate (higher in Group 1), urine output (2.0 vs 0.29 mL/m
in in Group 1 versus Group 2), urinary creatinine (66 vs 175 mg/dL), u
rinary osmolarity (370 vs 627 mOsm/L), osmolar clearance (2.1 vs 0.7 m
L/min), and urinary potassium (33 vs 71 mEq/L). There were no differen
ces between groups during hypo-and normothermic CPB. After CPB, the on
ly difference was a slightly higher urinary creatinine in Group 2. Ren
al plasma flow was lower than normal in all patients before the induct
ion of anesthesia. A nonsignificant trend toward increased flow was se
en during hypothermic CPB. Filtration fraction was high before CPB, wh
ich suggests efferent arteriolar vasoconstriction, descending toward n
ormal during and after CPB. The same pattern of changes was present in
both groups. In conclusion, there were no clinically relevant differe
nces between the two treatment modalities during and after CPB. Howeve
r, significant differences were observed before CPB, when dopamine see
med to partially revert renal vasoconstriction. Implications: Two prot
ective interventions were compared in patients undergoing heart surger
y to prevent deterioration of renal function; these were dopamine infu
sion throughout the operation and phenylephrine infusion during cardio
pulmonary bypass. We found clinically relevant differences only during
surgery before cardiopulmonary bypass.